NeuroOne Medical Technologies Corporation — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-11.7% -$382K
$3M
Cost of Revenue↓-1.7% -$22K
$1M
Gross Profit↓-18.6% -$359K
$2M
R&D↑+18.6% +$217K
$1M
SG&A↓-7.7% -$158K
$2M
D&A↑+0.6% +$396
$66K
Operating Income↓-199.8% -$3M
$-2M
EBITDA↓-192.4% -$3M
$-2M
Interest Expense
—
Other Income/Expense↑+263.5% +$195K
$269K
Pretax Income↓-180.5% -$3M
$-1M
Tax Provision
—
Net Income↓-180.5% -$3M
$-1M
Gross Margin↓-4.7pts
54.2%
Operating Margin↓-111.3pts
-59.0%
Net Margin↓-104.2pts
-49.7%
Effective Tax Rate
—
ETR (Continuing Operations)
—
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
7.7%
ETR Foreign Differential (pp)
—
Operating Lease Cost
—
Pension Net Periodic Cost
—
Revenue YoY Variation↓-246.6pts
-11.7%
Income YoY Variation↓-350.2pts
-199.8%
Revenue QoQ Variation↓-1096.9pts
5.5%
Income QoQ Variation↑+26.4pts
29.6%